Insider Stock Trading History of Bisgaier Charles Phd


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Bisgaier Charles Phd since year 2005. The trader's CIK number is 1381030. At the time of this reporting, Bisgaier Charles Phd is the Chief Scientific Off. & Chair of Gemphire Therapeutics Inc. . (stock ticker symbol GEMP). See this page for all insider trading activities at Gemphire Therapeutics Inc. .

Note that in the past Bisgaier Charles PhD also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Bisgaier Charles Phd since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-07-31 GEMP Gemphire Therapeutics Inc. Option Ex 4,474 1.34 6,013
2016-08-10 GEMP Gemphire Therapeutics Inc. Buy 51,750 10.00 517,500
2007-07-16 PP Sheffield Pharmaceuticals Inc Buy 10,000 4.64 46,400

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bisgaier Charles Phd (Chief Scientific Off. & Chair of Gemphire Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.